ALX Oncology Holdings Inc.
ALXO
$2.14
-$0.045-2.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.45M | 7.93M | 7.08M | 6.10M | 6.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.47M | 31.82M | 30.61M | 32.57M | 41.53M |
| Operating Income | -23.47M | -31.82M | -30.61M | -32.57M | -41.53M |
| Income Before Tax | -25.95M | -30.75M | -29.16M | -30.71M | -39.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.95M | -30.75M | -29.16M | -30.71M | -39.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.95M | -30.75M | -29.16M | -30.71M | -39.40M |
| EBIT | -23.47M | -31.82M | -30.61M | -32.57M | -41.53M |
| EBITDA | -23.28M | -31.61M | -30.40M | -32.34M | -41.31M |
| EPS Basic | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 |
| Normalized Basic EPS | -0.27 | -0.36 | -0.35 | -0.36 | -0.48 |
| EPS Diluted | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 |
| Normalized Diluted EPS | -0.27 | -0.36 | -0.35 | -0.36 | -0.48 |
| Average Basic Shares Outstanding | 53.45M | 53.36M | 52.80M | 52.69M | 51.83M |
| Average Diluted Shares Outstanding | 53.45M | 53.36M | 52.80M | 52.69M | 51.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |